HomeVTYX • NASDAQ
add
Ventyx Biosciences Inc
Previous close
$6.60
Day range
$5.74 - $6.96
Year range
$0.78 - $7.82
Market cap
414.30M USD
Avg Volume
5.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.33M | -17.86% |
Net income | -26.99M | 15.53% |
Net profit margin | — | — |
Earnings per share | -0.38 | 15.56% |
EBITDA | -29.27M | 17.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 208.96M | -12.73% |
Total assets | 230.01M | -25.61% |
Total liabilities | 20.63M | -27.37% |
Total equity | 209.38M | — |
Shares outstanding | 71.31M | — |
Price to book | 2.24 | — |
Return on assets | -30.33% | — |
Return on capital | -31.76% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.99M | 15.53% |
Cash from operations | -21.28M | 13.29% |
Cash from investing | 25.19M | 133.36% |
Cash from financing | 68.00K | 107.51% |
Net change in cash | 4.22M | 104.18% |
Free cash flow | -11.06M | 15.35% |
About
Founded
2018
Website
Employees
81
